DIG
ARMP icon

Dauntless Investment Group’s Armata Pharmaceuticals ARMP Stock Holding History

Dauntless Investment Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$928K Buy
90,580
+84,449
+1,377% +$711K 0.61% 22
2025
Q4 		$38.5K Buy
+6,131
New +$33.6K 0.03% 55

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Dauntless Investment Group's ARMP Position: Q1 2026 in Review

Dauntless Investment Group increased its Armata Pharmaceuticals (ARMP) stake by 1,377% in Q1 2026, buying an estimated $711K and bringing the position to 90,580 shares worth $928K. The position accounts for 0.61% of the portfolio, ranked #22.

Dauntless Investment Group first reported a position in ARMP in Q4 2025 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • Dauntless Investment Group held 90,580 shares of Armata Pharmaceuticals worth $928K as of Q1 2026.
  • Dauntless Investment Group bought 84,449 Armata Pharmaceuticals shares in Q1 2026, an estimated $711K.
  • Armata Pharmaceuticals made up 0.61% of Dauntless Investment Group's portfolio in Q1 2026, its #22 holding.
  • Dauntless Investment Group first reported a position in Armata Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Dauntless Investment Group's 13F filing for Q1 2026, filed 14 May 2026.